Brussels, 29/01/2015 (Agence Europe) - On Wednesday 20 January, the European Commission gave its green light, subject to conditions, to the planned acquisition of the 'Specialty and Branded Generic Business' activity of Abbott Laboratories by Mylan, Inc. on the non-US developed markets.
Abbott EPD-DM is a Swiss-based manufacturer of pharmaceutical products specialising in the distribution of branded ex-originator products with expired patents. It has internal production capabilities in...